PT005 MDI Dose Ranging Versus Foradil Aerolizer Study

Clinical trial NCT01349868 · COMPLETED

Trial details

NCT number: NCT01349868
Sponsor: Pearl Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2011-05-01
Primary completion: 2011-07-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.